|

Resmetirom Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Naga P. Chalasani1
  • Madrigal Pharmaceuticals, Inc.1

Indications

  • Liver Disease2
  • MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease1
  • HIV - Human Immunodeficiency Virus1
  • MASH1
  • MASH - Metabolic Dysfunction-Associated Steatohepatitis1

Birmingham, Alabama1 trial

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

University of Alabama Birmingham

Phase 2

Indianapolis, Indiana1 trial

Study of Resmetirom in Children and Adolescents With MASH

Riley Hospital for Children at IU Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.